The company monitors passenger feedback for risky driver behavior. Some accused of serious sexual assault had prior records ...

Caliway Biopharmaceuticals completes submission of IND application to US FDA for phase 2 study of CBL-514 for weight management: New Taipei City Monday, December 29, 2025, 11:00 H ...

BEIJING, Dec. 29, 2025 /PRNewswire/ -- iHuman Inc. (NYSE: IH) ('iHuman' or the 'Company'), a leading provider of tech-powered ...

NDA supported by results from a Phase II registration trial in China —— Second most common form of liver cancer after hepatocellular carcinoma, ...

The Greek Documentary Festival (DocFest) in Chalkida pays tribute to the Greek community of Australia, highlighting diasporic ...

The Museum of Contemporary Art has announced its 2026 exhibition schedule, a combination of bold commissions, collaborations ...

(Alliance News) - Hutchmed China Ltd on Monday said Chinese regulators have accepted a new drug application for its cancer treatment fanregratinib and granted it priority review status.

The Centro Escolar University (CEU) School of Dentistry proudly marked its 100th anniversary with a landmark celebration honoring a century of academic excellence, service, and leadership in dental ...

What are the predictions for markets in 2026? Read more on what Seeking Alpha analysts are saying about next year.

NDA supported by results from a Phase II registration trial in China - - Second most common form of liver cancer after hepatocellular carcinoma, with generally poorer long-term survival in comparison ...

Maintaining good oral hygiene, regular exercise and increasing your social interactions can help prevent or delay the onset ...

New tools and new supports, including AI, are being used to facilitate learning and communication in both local school boards ...